All In Biotech

Free tool

FAERS Monitor: Zonegran

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020789 or its brand name (Zonegran, Zonisamide). Reports on generic versions are filed under their own applications.

Reports

14,830

Serious

11,239

76% of reports

Hospitalization

4,583

Death reported

894

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,707
  • seizure1,667
  • off label use953
  • fatigue731
  • somnolence688
  • convulsion622
  • dizziness584
  • nausea581
  • headache569
  • fall521
  • drug interaction482
  • condition aggravated465
  • vomiting452
  • diarrhoea423
  • epilepsy408

Reports by year received

View as table
YearReports
2004166
2005182
2006245
2007236
2008268
2009305
2010329
2011490
2012518
2013446
2014547
2015777
2016937
2017706
2018891
20191,058
2020929
20211,148
20221,093
20231,023
2024969
2025946
2026621

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,329 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal1,66720.819.831,041
epilepsySignal40819.217.46,925
convulsionSignal62215.614.48,406
somnolenceSignal6884.94.52,118
drug interactionSignal4824.34.01,232
fallSignal5212.22.0354
condition aggravatedSignal4652.22.0296
drug ineffective1,7071.81.8694
dizziness5841.71.5157
off label use9531.51.5190
vomiting4521.41.244
fatigue7311.31.262
headache5691.31.237
nausea5811.01.01
diarrhoea4230.90.82

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.